Salim Syed Analyst PerformanceHead of Biotechnology Research | Senior Biotechnology Analyst | Managing Director at MizuhoSalim Syed is a stock analyst at Mizuho in the medical sector, covering 22 publicly traded companies. Over the past year, Salim Syed has issued 19 stock ratings, including strong buy, buy, and hold recommendations. While full access to Salim Syed's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Salim Syed's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings174 Last 9 YearsBuy Recommendations83.63% 143 Buy RatingsCompanies Covered22 Unique Companies Ratings Distribution171RatingsDistribution of strong buy, buy, hold, and sell ratings by Salim Syed.RatingPercentageCount Strong Buy1.2%2 ratings Buy82.5%141 ratings Hold15.8%27 ratings Sell0.6%1 ratingsOut of 171 total stock ratings issued by Salim Syed at Mizuho, the majority (82.5%) have been Buy recommendations, followed by 15.8% Hold, 1.2% Strong Buy, and 0.6% Sell.Best & Worst CallsBest Call0000.0%WVEJun 2020Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%BBIOMar 2021Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ95.5% of companies on NASDAQ21 companiesNYSE4.5% of companies on NYSE1 companySalim Syed, an analyst at Mizuho, currently covers 22 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical22 companies100.0%Salim Syed of Mizuho specializes in stock coverage within the Medical sector.Coverage IndustriesIndustryPercentageMED - BIOMED/GENE16 companies72.7%MED - DRUGS4 companies18.2%MED - GENERIC DRG2 companies9.1% Salim Syed's Ratings History at Mizuho Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsSTROSutro Biopharma4/30/2026Set Price Target$35.39$50.00Outperform$0.0000.00% ROISTROSutro Biopharma4/30/2026Upgrade$36.62$50.00Strong-Buy$0.0000.00% ROIBBIOBridgeBio Pharma4/28/2026Reiterated Rating$73.18$106.00Outperform$0.0000.00% ROIAUTLAutolus Therapeutics3/31/2026Lower Price Target$1.36$10.00Outperform$0.0000.00% ROISNDXSyndax Pharmaceuticals3/31/2026Lower Price Target$22.71$43.00Outperform$0.0000.00% ROINKTXNkarta3/31/2026Lower Price Target$2.09$12.00Outperform$0.0000.00% ROIWVEWAVE Life Sciences3/25/2026Boost Price Target$12.42$27.00Outperform$0.0000.00% ROIELVNEnliven Therapeutics3/25/2026Boost Price Target$35.80$45.00Outperform$0.0000.00% ROICYTKCytokinetics3/18/2026Boost Price Target$62.57$100.00Outperform$0.0000.00% ROIBBIOBridgeBio Pharma3/18/2026Boost Price Target$70.62$106.00Outperform$0.0000.00% ROIMAZEMaze Therapeutics3/11/2026Upgrade$51.83Strong-Buy$0.0000.00% ROIMAZEMaze Therapeutics3/10/2026Initiated Coverage$45.06$97.00Outperform$0.0000.00% ROIINCYIncyte12/8/2025Set Price Target$102.52$121.00Outperform$0.0000.00% ROIINCYIncyte12/8/2025Upgrade$96.70$121.00Outperform$0.0000.00% ROIASMBAssembly Biosciences11/20/2025Set Price Target$39.03$40.00Outperform$0.0000.00% ROINKTXNkarta6/10/2025Lower Price Target$2.00$14.00Outperform$0.0000.00% ROICYTKCytokinetics5/29/2025Lower Price Target$30.75$84.00Outperform$0.0000.00% ROIBIIBBiogen5/7/2025Lower Price Target$116.92$169.00Outperform$0.0000.00% ROIAMGNAmgen5/7/2025Boost Price Target$271.64$280.00Neutral$0.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageThe Goldman Sachs GroupBTIG ResearchDA DavidsonRoth MkmWall Street ZenUBS GroupCitigroupBarclaysWells Fargo & CompanyMorgan StanleyRoyal Bank Of CanadaJPMorgan Chase & Co.Jefferies Financial GroupTD CowenTruist Financial Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
